Margerison CE, Roberts MH, Gemmill A, Goldman-Mellor S. Pregnancy-associated deaths due to drugs, suicide, and homicide in the United States, 2010–2019. Obstet Gynecol. 2022;139(2):172–80.

Article  PubMed  PubMed Central  Google Scholar 

Hall OT, Hall OE, Rood KM, McKiever ME, Teater J, Senay A. Pregnancy-associated mortality due to accidental drug overdose and suicide in Ohio, 2009–2018. Obstet Gynecol. 2020;136(4):654.

Article  PubMed  Google Scholar 

Trost S, Beauregard J, Chandra G, Njie F, Berry J, Harvey A, et al. Pregnancy-related deaths: data from maternal mortality review committees in 36 US states, 2017–2019 | CDC [Internet]. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2022 [cited 2022 Nov 16]. Available from: https://www.cdc.gov/reproductivehealth/maternal-mortality/erase-mm/data-mmrc.html.

American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. Obstet Gynecol. 2017;130:81–94.

Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for unhealthy drug use: US Preventive Services Task Force Recommendation statement. JAMA. 2020;323(22):2301.

American College of Obstetricians and Gynecologists. Obstetric care for women with opioid use disorder. Patient Safety Bundle. 2017.

Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016;215(5):539–47.

Article  PubMed  Google Scholar 

Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of. Am J Obstet Gynecol. 2019;1–24.

Ondersma SJ, Chang G, Blake-Lamb T, Gilstad-Hayden K, Orav J, Beatty JR, et al. Accuracy of five self-report screening instruments for substance use in pregnancy. Addiction. 2019;114:1683–93.

Article  PubMed  PubMed Central  Google Scholar 

Chang G, Ondersma SJ, Blake-Lamb T, Gilstad-Hayden K, Orav EJ, Yonkers KA. Identification of substance use disorders among pregnant women: a comparison of screeners. Drug Alcohol Depend. 2019;1(205): 107651.

Article  Google Scholar 

Coleman-Cowger VH, Oga EA, Peters EN, Trocin KE, Koszowski B, Mark K. Accuracy of three screening tools for prenatal substance use. Obstet Gynecol. 2019;133(5):952–61.

Article  PubMed  PubMed Central  Google Scholar 

• Ulrich M, Memmo EP, Cruz A, Heinz A, Iverson RE. Implementation of a universal screening process for substance use in pregnancy. Obstet Gynecol. 2021;137(4):695–701. This quality improvement study demonstrated the successful implementation of universal substance use screening in the form of a validated screen in prenatal care.

Anderson BL, Dang EP, Floyd RL, Sokol R, Mahoney J, Schulkin J. Knowledge, opinions, and practice patterns of obstetrician-gynecologists regarding their patients’ use of alcohol. J Addict Med. 2010;4(2):114.

Article  PubMed  Google Scholar 

Oni HT, Buultjens M, Blandthorn J, Davis D, Abdel-latif M, Islam MM. Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: a qualitative study of midwives’ experience. Midwifery. 2020;81:102595.

Krans EE, Kim JY, Chen Q, Rothenberger SD, James AE, Kelley D, et al. Outcomes associated with the use of medications for opioid use disorder during pregnancy. Addict Abingdon Engl. 2021;116(12):3504–14.

Article  Google Scholar 

Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ordean A, Tubman-Broeren M. Safety and efficacy of buprenorphine-naloxone in pregnancy: a systematic review of the literature. Pathophysiology. 2023;30(1):27–36.

Article  PubMed  PubMed Central  Google Scholar 

Kanervo MM, Tupola SJ, Nikkola EM, Rantakari KM, Kahila HK. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder. Acta Obstet Gynecol Scand. 2022;102(3):313–22.

Article  PubMed  PubMed Central  Google Scholar 

Hulse G, Arnold-Reed D, O’Neil G. Methadone maintenance versus implantable naltrexone treatment in the pregnant heroin user. Int J Gynecol Obstet. 2004;85(2). Available from: https://researchonline.nd.edu.au/med_article/63.

Farid WO, Dunlop SA, Tait RJ, Hulse GK. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol. 2008;6(2):125–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelty E, Hulse G. A Retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls. Drugs. 2017;77(11):1199–210.

Article  CAS  PubMed  Google Scholar 

Wachman EM, Saia K, Miller M, Valle E, Shrestha H, Carter G, et al. Naltrexone treatment for pregnant women with opioid use disorder compared with matched buprenorphine control subjects. Clin Ther. 2019;41(9):1681–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Towers CV, Katz E, Weitz B, Visconti K. Use of naltrexone in treating opioid use disorder in pregnancy. Am J Obstet Gynecol. 2020;222(1):83.e1-83.e8.

Article  CAS  PubMed  Google Scholar 

Stubbs A, Szoeke C. The effect of intimate partner violence on the physical health and health-related behaviors of women: a systematic review of the literature. Trauma Violence Abuse. 2022;23(4):1157–72.

Article  PubMed  Google Scholar 

Driscoll Powers L, Cook PF, Weber M, Techau A, Sorrell T. Comorbidity of lifetime history of abuse and trauma with opioid use disorder: implications for nursing assessment and care. J Am Psychiatr Nurses Assoc. 2022;10:10783903221083260.

Google Scholar 

Gannon M, Short V, Becker M, Parikh S, McGuigan K, Hand D, et al. Doula engagement and maternal opioid use disorder (OUD): experiences of women in OUD recovery during the perinatal period. Midwifery. 2022;1(106): 103243.

Article  Google Scholar 

Abuse S. Mental Health Services Administration. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. Rockville, MD: Substance Abuse and Mental Health Services Administration; [cited 2023 Sep 20] 2014;1–27. Report No.: HHS Publication No. (SMA) 14–4884. Available from: https://store.samhsa.gov/product/SAMHSA-s-Concept-of-Trauma-and-Guidance-for-a-Trauma-Informed-Approach/SMA14-4884.

Caring for Patients Who Have Experienced Trauma. ACOG Committee Opinion Summary, Number 825. Obstet Gynecol. 2021;137(4):757.

Article  Google Scholar 

Huybrechts KF, Hernandez-Diaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiat. 2016;73(9):938–46.

Article  Google Scholar 

Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):842–50.

Article  PubMed  PubMed Central  Google Scholar 

Patrick SW, Barfield WD, Poindexter BB, Committee on fetus and newborn cosuap, Cummings J, Hand I, et al. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146(5):e2020029074.

Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A novel approach to assessing infants with neonatal abstinence syndrome. Hosp Pediatr. 2018;8(1):1–6.

Article  PubMed  Google Scholar 

Ferguson v. Charleston. U.S. Supreme Court; 2001 [cited 2023 Oct 3]. Report No.: 532. Available from: https://supreme.justia.com/cases/federal/us/532/67/.

• Siegel MR, Mahowald GK, Uljon SN, James K, Leffert L, Sullivan MW, et al. Fentanyl in the labor epidural impacts the results of intrapartum and postpartum maternal and neonatal toxicology tests. Am J Obstet Gynecol [Internet]. 2022 Nov 23 [cited 2023 Apr 23]; Available from: https://www.sciencedirect.com/science/article/pii/S0002937822021858. This prospective cohort study showed that fentanyl in labor epidurals can lead to positive maternal toxicology tests intra- and postpartum, as well as positive toxicology tests in the neonate, which has implications for the interpretation of positive toxicology tests in parturients.

Kozhimannil KB, Vogelsang CA, Hardeman RR, Prasad S. Disrupting the pathways of social determinants of health: doula support during pregnancy and childbirth. J Am Board Fam Med JABFM. 2016;29(3):308–17.

Article  PubMed  Google Scholar 

Bey A, Brill A, Porchia-Albert C, Gradilla M, Strauss N. Advancing birth justice: community-based doula models as a standard of care for ending racial disparities. New York, NY: Every Mother Counts. 2019;1–33.

Arcara J, Cuentos A, Abdallah O, Armstead M, Jackson A, Marshall C, et al. What, when, and how long? Doula time use in a community doula program in San Francisco, California. Womens Health. 2023;4(19):17455057231155302.

Google Scholar 

Mottl-Santiago J, Dukhovny D, Cabral H, Rodrigues D, Spencer L, Valle EA, et al. Effectiveness of an enhanced community doula intervention in a safety net setting: a randomized controlled trial. Health Equity. 2023;7(1):466–76.

Nehme EK, Wilson KJ, McGowan R, Schuessler KR, Morse SM, Patel DA. Providing doula support to publicly insured women in central Texas: a financial cost–benefit analysis. Birth [Internet]. [cited 2023 Sep 21];n/a(n/a). Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/birt.12766.

Sobel L, O’Rourke-Suchoff D, Holland E, Remis K, Resnick K, Perkins R, et al. Pregnancy and childbirth after sexual trauma: patient perspectives and care preferences. Obstet Gynecol. 2018;132(6):1461.

Article  PubMed  Google Scholar 

•• Smid MC, Terplan M. What obstetrician–gynecologists should know about substance use disorders in the perinatal period. Obstet Gynecol. 2022;139(2):317. This clinical expert series provides a comprehensive review of the management of important substance use disorders in pregnancy.

Randhawa PA, Brar R, Nolan S. Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market. CMAJ Can Med Assoc J. 2020;192(3):E73.

Article  CAS  Google Scholar 

Spreen LA, Dittmar EN, Quirk KC, Smith MA. Buprenorphine initiation strategies for opioid use disorder and pain management: a systematic review. Pharmacotherapy. 2022;42(5):411–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holland E, Sudhof LS, Zera C. Optimal pain management for cesarean delivery. Int Anesthesiol Clin. 2020;58(2):42. Spring.

Hedderson M, Lee D, Hunt E, Lee K, Xu F, Mustille A, et al. Enhanced recovery after surgery to change process measures and reduce opioid use after cesarean delivery. Obstet Gynecol. 2019;134(3):1.

Article  Google Scholar 

Macias DA, Adhikari EH, Eddins M, Nelson DB, McIntire DD, Duryea EL. A comparison of acute pain management strategies after cesarean delivery. Am J Obstet Gynecol. 2022;226(3):407.e1-407.e7.

Article  PubMed  Google Scholar 

• Alliance for Innovation on Maternal Health. Care for pregnant and postpartum people with substance use disorder patient safety bundle [Internet]. 2021 [cited 2023 Sep 25]. Available from: https://saferbirth.org/psbs/care-for-pregnant-and-postpartum-people-with-substance-use-disorder/. This document provides updated guidance on the implementation of best practices for perinatal substance use.

Dodds D, Koch K, Buitrago-Mogollon T, Horstmann S. Successful implementation of the eat sleep console model of care for infants with NAS in a community hospital. Hosp Pediatr. 2019;9(8):632–8.

Article  PubMed  Google Scholar 

Parlaman J, Deodhar P, Sanders V, Jerome J, McDaniel C. Improving care for infants with neonatal abstinence syndrome: a multicenter, community hospital–based study. Hosp Pediatr. 2019;9(8):608–14.

Article  PubMed  Google Scholar 

• Young LW, Ounpraseuth ST, Merhar SL, Hu Z, Simon AE, Bremer AA, et al. Eat, Sleep, Console approach or usual care for neonatal opioid withdrawal. N Engl J Med. 2023;388(25):2326–37. This cluster randomized controlled trial showed that Eat, Sleep, Console decreased length of stay for infants with neonatal opioid withdrawal syndrome without increasing adverse outcomes.

Amin A, Frazie M, Thompson S, Patel A. Assessing the Eat, Sleep, Console model for neonatal abstinence syndrome management at a regional referral center. J Perinatol. 2023;25:1–7.

Google Scholar 

MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB, Volpe HA. Association of rooming-in with outcomes for neonatal abstinence syndrome. JAMA Pediatr. 2018;172(4):345–51.

Article  PubMed  PubMed Central  Google Scholar 

Patrick SW, Schumacher RE, Horbar JD, Buus-Frank ME, Edwards EM, Morrow KA, et al. Improving care for neonatal abstinence syndrome. Pediatrics. 2016;137(5): e20153835.

Article